Concerns have arisen in the state of Karnataka regarding the pricing of critically important medications, including oncology drugs, expensive injectable agents, implants, and surgical consumables, as well as diagnostic consumables and disposable devices.
The Commissioner of the Food and Drug Administration of Karnataka, K. Srinivasa, demanded urgent regulatory intervention on pricing issues. This pertains to medicines, medical devices, and consumables supplied to hospitals at reduced institutional prices but subsequently charged to inpatients at the printed maximum retail price (MRP) or very close to it.

